Nefropati diabetik telah diketahui merupakan salah satu penyulit jangka panjang diabetes melitus (DM) 
Diabetic nephropathy is a clinical syndrome characterized by persistent albuminuria of more than 300 mL/ 24 hour and retinopathy without clinical signs of renal or urinary tract disturbance among Diabetics. 1, 2 The prevalence of type 2 diabetes mellitus (DM) patients who progress to diabetic nephropathy is 20-30%. In September 1998, World Health Organization (WHO) estimated that the prevalence of type 2 DM patients will increase by 41%, i.e. from 51 millions in 1995 to 92 millions in 2005.
Diabetic nephropathy is a leading cause of morbidity and mortality among type 2 DM patients. If albuminuria present, there will be a reduction of 2-20 mL/min of glomerular filtration rate (GFR) per year. 1, 2 Sitompul has reported that the prevalence of microalbuminuria and macroalbuminuria in type 2 DM were 6.9% and 8.6%, respectively. 3 Hariyono found that the prevalence of microalbuminuria and macroalbuminuria were 31.3% and 4.4%, respectively. Further observation showed that after 1.5-year, 40.4% of the normoalbuminuria group became microalbuminuria, while in the group of microalbuminuria, 8.4% became macroalbuminuria. 4 Currently there is no data on the prevalence of diabetic nephropathy among type 2 diabetic patients in terms of the persistence of microalbuminuria or macroalbuminuria. Although Dr. Cipto Mangunkusumo Hospital is a referral hospital, many diabetic patients come without reference from other medical facilities. The objective of this study was to find the prevalence of diabetic nephropathy among type 2 DM patients and its correlation with several clinical parameters that came to the Endocrinology-Metabolic Clinic for the first time, with or without reference from other medical facilities.
METHODS

Patients
This was a cross-sectional study conducted between December 2001 and June 2002. All new type 2 diabetic patients in the Endocrinology-Metabolic Clinic Dr. Cipto Mangunkusumo Hospital were included if they were willing to join the study. Patients with urinary tract infection, fever, heart failure or liver cirrhosis were excluded. Eligible patients underwent a thorough anamnesis, physical examination and laboratory testing which included urinalysis, blood chemistry, lipid profile and HbA 1 c level.
All patients then underwent quantitative albuminuria testing. Urinary dipstick test was done to detect albuminuria. Positive result with urinary albumincreatinine ratio > 300 mg/g (macroalbuminuria) was designated as overt nephropathy. Urinary albumincreatinine ratio was also calculated in patients with negative result. If the value was between 30-300 mg/g (microalbuminuria), it is designated as incipient nephropathy. A value below 30 mg/g was designated normoalbuminuria. Persistent microalbuminuria was established if the patient showed positive microalbuminuria in the first and repeated tests. Patients with persistent microalbuminuria underwent funduscopy examination to find the presence of retinopathy in the Department of Ophthalmology.
Risk factors
Clinical data were obtained from the patients to assess risk factors, which contribute to microalbuminuria. They included the patient's age (below or above 40 years), duration of illness (more or less than 5 years), hypertension ( 
Statistical Analysis
Descriptive statistics was performed to patient characteristics and risk factors. Correlations between microalbuminuria and risk factors were tested using non-parametric test (Chi-square and KolmogorovSmirnov tests). A p value below 0.05 was significant. Significant factors were further tested using multivariate analysis. All statistical analyses were done by statistical software system SPSS for Windows version 10.0.
RESULTS
There were 125 new type 2 DM patients during the study period. From this number, 100 patients met the inclusion and exclusion criteria and eligible for the study. Eleven percents of the patients had macroalbuminuria, 25% had microalbuminuria and the rest were normal. The demographic data of the patients were presented in Table 1 .
The correlation between diabetic nephropathy and its risk factors is presented in Table 2 . There was a correlation between the duration of illness and the presence of diabetic nephropathy. However, there was no correlation between diabetic nephropathy and the concentration of HbA 1 c, body mass index, total cholesterols, triglyceride level and hypertension.
Predictive calculated creatinine clearance test (CCT) among patients is presented in Table 3 . The lowest CCT was found in patients with overt nephropathy (macroalbuminuria). There is a significant difference among the three groups of patients although the CCT was almost similar in patients with normoalbuminuria and microalbuminuria.
Retinopathy was found in 24 (24%) patients. Three out of 60 patients in normoalbuminuria group has already developed nephropathy. In contrast, only one patient with overt nephropathy did not show retinopathy. The difference is very significant ( Table 4 ). 
DISCUSSION
Our study found that albuminuria occurred in 37% of patients, i.e. 26% with microalbuminuria or insipient nephropathy and 11% with macroalbuminuria or overt nephropathy. These findings were quite similar to other studies. Viberti et al 5 , Varghese et al 6 and Parving et al 7 found that macroalbuminuria was present in 16%, 6.9%, and 13.8% of diabetic patients, respectively, whereas Savage et al 8 found that the prevalence of microalbuminuria was between 25-36%.
Risk factors analysis did not show significant correlation to the prevalence of diabetic nephropathy, except the duration of illness. It is probably due to the design of our study, which was cross-sectional rather than a prospective study. However, many investigators also found no correlation among diabetic nephropathy and several risk factors. Varghese et al, did not find any correlation between body mass index and the prevalence of diabetic nephropathy. 6 Schmitz et al 9 did not find a significant correlation between HbA 1 c level and the prevalence of diabetic nephropathy. Despite the fact that hypertension contribute to the progression of diabetic nephropathy, a study performed in Mayo Clinic did not find a correlation between hypertension and proteinuria or chronic renal failure.
10
Duration of illness is an important factor for the development of diabetic nephropathy. Our current study found that albuminuria occurred in 60.6% patients who had suffered for more than 5 years, but only 25.4% in patients who had the disease less than 5 years (Table 2 ). This figure was very high. Several studies reported previously that the incidence of proteinuria below 5 years of illness is 7-10% and after 20-25 years, the number increased to 20-35%. Another report also showed that the occurrence of proteinuria was 17% after 15 years of illness. 11, 12, 13 All patients with overt nephropathy had predictive calculated CCT below 75 mL/min. Diabetic nephropathy could reduce renal function due to glomerulosclerosis, tubulointerstitial atrophy and this condition will decrease the glomerular filtration rate. Davies et al 14 reported a clear relationship between nephropathy and reduced GFR among diabetic patients, which has suffered for 8 to11 years.
The presence of diabetic nephropathy implies that there is a systemic endothelial dysfunction, including in the retina. However, not all patients with diabetic nephropathy would develop retinopathy. We found that 24% patients presented with retinopathy, and 90% of patients with overt nephropathy had retinopathy. This finding is quite similar to a study by McKay 15 who found that the prevalence of retinopathy is 29.1%. Parving et al also reported that 76% patients with diabetic nephropathy had retinopathy. 7 
CONCLUSION
This study found that the prevalence of macroalbuminuria and microalbuminuria were 11% and 26%, respectively, in non-hospitalized type 2 diabetic patients who came to Dr. Cipto Mangunkusumo Hospital for the first time. Diabetic nephropathy, i.e. overt nephropathy with retinopathy was observed in 10% of patients. There was a significant correlation between the presence of diabetic nephropathy and duration of diabetes mellitus.
